Roelof Rongen
2014
In 2014, Roelof Rongen earned a total compensation of $618.8K as Chief Executive Officer at Matinas BioPharma Holdings.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $268,813 |
| Salary | $300,000 |
| Total | $618,813 |
Rongen received $300K in salary, accounting for 48% of the total pay in 2014.
Rongen also received $50K in bonus and $268.8K in option awards.
Rankings
In 2014, Roelof Rongen's compensation ranked 9,555th out of 13,032 executives tracked by ExecPay. In other words, Rongen earned more than 26.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,555 out of 13,032 | 27th |
Division Manufacturing | 3,606 out of 4,967 | 27th |
Major group Chemicals And Allied Products | 1,231 out of 1,690 | 27th |
Industry group Drugs | 974 out of 1,369 | 29th |
Industry Pharmaceutical Preparations | 746 out of 1,042 | 28th |
Source: SEC filing on September 22, 2016.
Rongen's colleagues
We found two more compensation records of executives who worked with Roelof Rongen at Matinas BioPharma Holdings in 2014.